The drug eluting stents market globally was USD 7.21 Billion in 2022. It is projected to reach USD 12.18 Billion by 2032, with a revenue growth rate of 6% during the forecast period. One of the primary drivers of revenue growth in the drug eluting stent market is the increasing incidence of cardiovascular disorders, including coronary artery disease and peripheral artery disease. These conditions pose a significant health burden globally, with approximately 18 million deaths attributed to cardiovascular illnesses each year, making them the leading cause of mortality worldwide. Factors such as an aging population and sedentary lifestyle have further contributed to the increased risk of developing cardiovascular diseases, thereby raising the demand for drug eluting stents. https://www.reportsanddata.com..../report-detail/drug-
